Summary
ESR 1: “The role of SK channels in healthy and fibrillating atria: in silico modeling of drug binding, calcium dynamics and biophysical properties”
ESR 2: “Establishing an AF pig model for electrophysiological and pharmacological investigations”
ESR 3: “SK channel inhibition by different mechanisms of action”
ESR 4: “Regulation and quantification of atrial ISK“
ESR 5: “Regulation and importance of human atrial SK channels in health and disease”
ESR 6: “Atrial action potential frequency dependence and intracellular Ca2+ transients in normal and failing hearts”
ESR 7: “Dynamic-clamping of human atrial cells: contribution of ISK to action potential changes in AF”
ESR 8: “Multicellular in silico model of AF: Atrial calcium dynamics and electrophysiology from cell to organ at different stages of atrial fibrillation”
ESR 9: “From paroxysmal to permanent AF – exploitation of an AF goat model”
ESR 10: “Development and exploitation of AF in horses”
ESR 11: “Studying atrial and ventricular remodeling in the dish in human iPSC-derived engineered heart tissues”
ESR 12: “Cardiotoxicology and therapeutic profiles of novel drugs using human ES-derived cardiomyocytes”
ESR 13: “Regulation of IK,Ach in the atria”
ESR 14: “Importance of IK,Ach for action potential adaptation and atrial fibrillation”
ESR 15: “Treatment of AF by IK,Ach Blockers“
More information & hyperlinks